Search - tctmd.com

Displaying 301 - 320 of 401

Sort: Relevancy | Date

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Michael O'Riordan

April 17, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Caitlin E. Cox

March 14, 2018

News Conference News ACC 2018

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

Todd Neale

March 12, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Daily News

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Yael L. Maxwell

March 08, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Yael L. Maxwell

January 24, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Daily News

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Yael L. Maxwell

December 12, 2017

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

Top Stories in Cardiology, November 2017

Podcast Heart Sounds

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Advertisement

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Genetic Study Hints at Role of Lipids in AAA Risk

TCTMD’s Top 10 Most Popular Stories for November 2017

Top Stories in Cardiology, November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content